Fetal growth regulation via insulin-like growth factor axis in normal and diabetic pregnancy

• Published in: Journal of perinatal medicine Vol. 50; no. 7; pp. 947 - 960
• Main Authors: Alekseenkova, Elena N., Selkov, Sergey A., Kapustin, Roman V.
• Format: Journal Article
• Language: English
• Published: Germany De Gruyter 27.09.2022
• Subjects: birth weight; diabetes mellitus; fetal growth; IGF; insulin-like growth factor; macrosomia; birth weight; IGF; diabetes mellitus; insulin-like growth factor; fetal growth; macrosomia
• ISSN: 0300-5577; 1619-3997
• DOI: 10.1515/jpm-2021-0510

Diabetes mellitus (DM) in pregnancy and gestational diabetes remain a considerable cause of pregnancy complications, and fetal macrosomia is among them. Insulin, insulin-like growth factors (IGFs), and components of their signal-transduction axes belong to the predominant growth regulators and are implicated in glucose homeostasis. This study aimed to evaluate the available evidence on the association between the IGF axis and fetal anthropometric parameters in human diabetic pregnancy. PubMed, Medline, Web of Science, and CNKI databases (1981-2021) were searched. Maternal and cord serum IGF-I levels are suggested to be positively associated with weight and length of neonates born to mothers with type 1 DM. The results concerning IGF-II and IGFBPs in type 1 DM or any of the IGF axis components in type 2 DM remain controversial. The alterations of maternal serum IGFs concentrations throughout diabetic and non-diabetic pregnancy do not appear to be the same. Maternal 1st trimester IGF-I level is positively associated with fetal birth weight in DM. Research on the IGF axis should take gestational age of sampling, presence of DM, and insulin administration into account. Maternal 1st trimester IGF-I level might become a predictor for macrosomia development in diabetic pregnancy.